RLAY FY2025 SEC EDGAR DEF 14A #136 of 168 in industry

Relay Therapeutics, Inc. CEO pay ratio

The CEO earned $4.6M in FY2025 against median worker pay of $312,573 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-28
Industry
Chemicals & Pharmaceuticals
Industry rank
#136/168

Data updated August 2026

Subscribe to Relay Therapeutics, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
15:1
Below Average (Scale: 0–1000:1)
CEO pay
$4.6M
Median worker
$312,573

Answer first

Relay Therapeutics, Inc.'s FY2025 CEO total of $4.6M ranks #955 of 1,423 complete filings; its 15:1 pay ratio ranks #1252. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $312,573. Industry placement uses the FY2025 SIC-28 peer cohort (# 136 of 168, 20th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#955
$4.6M of 1,423 FY2025
Ratio rank
#1252
15:1 of 1,423
Industry pct
20th
among the lower quartile of industry peers by pay ratio

How Relay Therapeutics, Inc. ranks nationally

Relay Therapeutics, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$4,646,454 33rd percentile higher than 33% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). This entry sits in this band. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Relay Therapeutics, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($4.6M) against pay ratio (15:1) for Relay Therapeutics, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3336673.94531708.957267446921779.08116814.110.5:118.8:127:135.3:143.5:1CEO total payPay ratio (CEO : median worker)Relay Therapeutics, Inc., CEO total pay: 4646454 · Pay ratio (CEO : median worker): 15:1Relay Therapeutics, Inc.Lexicon Pharmaceuticals, Inc., CEO total pay: 3553953 · Pay ratio (CEO : median worker): 13:1Lexicon Pharmaceuticals, Inc.Intellia Therapeutics, Inc., CEO total pay: 5117748 · Pay ratio (CEO : median worker): 17:1Intellia Therapeutics, Inc.Organogenesis Holdings Inc., CEO total pay: 6811754 · Pay ratio (CEO : median worker): 17:1Organogenesis Holdings Inc.Lifecore Biomedical, Inc. \de\, CEO total pay: 6547620 · Pay ratio (CEO : median worker): 12:1Lifecore Biomedical, Inc. \de\Agios Pharmaceuticals, Inc., CEO total pay: 5456520 · Pay ratio (CEO : median worker): 18:1Agios Pharmaceuticals, Inc.
Relay Therapeutics, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Relay Therapeutics, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Relay Therapeutics, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
15:1
FY2025
vs prior FY
-29:1
from FY2024 44:1
CEO $ YoY
-64%
$4.6M latest
Filings shown
4
FY2022–2025
Relay Therapeutics, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $8.1M - $300,363 27:1 -
2023 $19.8M +143% $328,908 60:1 +33:1
2024 $13.1M -34% $298,080 44:1 -16:1
2025 $4.6M -64% $312,573 15:1 -29:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1812364, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
15:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$4.6M
Companies in Industry
168
vs. Industry Median
Below
#136 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Relay Therapeutics, Inc.: near-parity Item 402(u) ratio

Relay Therapeutics, Inc.'s FY2025 ratio 15:1 ranks #136 of 168 Chemicals & Pharmaceuticals filers (20th percentile). the CEO earned 15× the median employee ($312,573) in FY2025.

At $312,573 median worker pay, the FLOOR stamp is near pay-parity territory under MID$ CEO total.

CEO Total Pay

$4.6M

FY2025 Summary Compensation, below median

Pay Ratio

15:1

Below typical

Relay Therapeutics, Inc. in the lower Chemicals & Pharmaceuticals third

Relay Therapeutics, Inc.'s FY2025 ratio 15:1 ranks #136 of 168 Chemicals & Pharmaceuticals filers (20th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Relay Therapeutics, Inc.'s $4.6M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #955 and ratio rank #1252 split - treat 15:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$4.6M
Median Employee Pay
$312,573
Pay Ratio
15:1
Filing Date
2026-04-28

Company Info

Ticker
RLAY
CIK
1812364
Industry
Chemicals & Pharmaceuticals
SIC Code
2836
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1812364, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Relay Therapeutics, Inc.'s FY2025 ratio 15:1 ranks #136 of 168 Chemicals & Pharmaceuticals filers (20th percentile).

Read with Relay Therapeutics, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MID$ · ELITE-MED.

Dine Brands Global, Inc. · MID$

ABS(ceo_total_comp) peer at $4.6M (Δ $2K lighter vs Relay Therapeutics, Inc.); STEEP · LOW-MED vs this page's FLOOR · MID$ · ELITE-MED.
Wendy's Co · MID$

ABS(ceo_total_comp) peer at $4.6M (Δ $18K lighter vs Relay Therapeutics, Inc.); STEEP · LOW-MED vs this page's FLOOR · MID$ · ELITE-MED.
RxSight, Inc. · MID$

ABS(ceo_total_comp) peer at $4.6M (Δ $31K lighter vs Relay Therapeutics, Inc.); MODEST · ELITE-MED vs this page's FLOOR · MID$ · ELITE-MED.
TrueBlue, Inc. · MID$

ABS(ceo_total_comp) peer at $4.6M (Δ $35K lighter vs Relay Therapeutics, Inc.); HIGH · LOW-MED vs this page's FLOOR · MID$ · ELITE-MED.
Lexicon Pharmaceuticals, Inc. (SIC 28 pole)

Lexicon Pharmaceuticals, Inc. stamps FLOOR · MID$ nearest in-SIC by ABS(pay_ratio) to Relay Therapeutics, Inc.'s FLOOR filing.
National dual ranks · #955/#1252

Relay Therapeutics, Inc.'s FY2025 package sits #955 by CEO dollars and #1252 by ratio under MID$ · FLOOR.
Ratio primer · FLOOR

Relay Therapeutics, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Relay Therapeutics, Inc. (CIK 1812364), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.